Qiagen NV | QIA - Operating Profit

Stock Price
41.79
Daily Change
0.40 0.97%
Monthly
-6.54%
Yearly
13.47%
Q1 Forecast
40.37

Qiagen NV reported $121.88M in Operating Profit for its fiscal quarter ending in December of 2025.





Operating Profit Change Date
Akebia Therapeutics USD 13.51M 27.82M Mar/2025
Alaunos Therapeutics USD -1.19M 432K Sep/2025
argenx SE USD 371.14M 21.17M Dec/2025
Avita Medical AUD -11.15M 1.19M Jun/2025
Dianthus Therapeutics USD -40.29M 5.36M Sep/2025
Ionis Pharmaceuticals USD -215M 54.82M Dec/2025
IQVIA Holdings USD 2.68B 2.1B Dec/2025
Moderna USD -857M 597M Dec/2025
Organon & Co USD 388M 62M Sep/2025
Qiagen NV USD 121.88M 15.41M Dec/2025
Revvity USD 145.83M 47.49M Dec/2025
Tectonic Therapeutic USD -21.89M 440K Sep/2025
Viatris USD -157.5M 392M Dec/2025
Xeris Pharmaceuticals USD 6.73M 2.25M Sep/2025